Biotech M&A boom sees Sanofi snapping up Ablynx 11:07am EST - 01:01 
French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock   
French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock  //reut.rs/2noW8dB